CNR Institutional Research Information System

MARI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.383
NA - Nord America 2.979
SA - Sud America 1.362
EU - Europa 1.358
AF - Africa 275
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.370
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.342
US - Stati Uniti d'America 2.672
CN - Cina 1.095
BR - Brasile 979
HK - Hong Kong 659
VN - Vietnam 544
IT - Italia 393
BD - Bangladesh 315
FR - Francia 310
KR - Corea 201
DE - Germania 175
IN - India 174
TR - Turchia 157
IQ - Iraq 119
MX - Messico 116
RU - Federazione Russa 108
JP - Giappone 101
AR - Argentina 95
SA - Arabia Saudita 87
VE - Venezuela 86
PH - Filippine 83
UA - Ucraina 72
UZ - Uzbekistan 72
ID - Indonesia 70
MY - Malesia 66
CA - Canada 64
MA - Marocco 64
GB - Regno Unito 60
EC - Ecuador 54
KE - Kenya 52
NL - Olanda 47
ZA - Sudafrica 47
CO - Colombia 46
FI - Finlandia 45
IR - Iran 45
JM - Giamaica 36
UY - Uruguay 36
PY - Paraguay 35
JO - Giordania 32
AZ - Azerbaigian 31
EG - Egitto 29
IL - Israele 28
KZ - Kazakistan 28
HN - Honduras 25
MM - Myanmar 24
CR - Costa Rica 23
NP - Nepal 23
PK - Pakistan 21
PL - Polonia 20
AL - Albania 19
ES - Italia 19
TN - Tunisia 18
DZ - Algeria 17
AT - Austria 14
GE - Georgia 13
BG - Bulgaria 12
CL - Cile 12
PA - Panama 12
BO - Bolivia 11
CI - Costa d'Avorio 10
AM - Armenia 9
KG - Kirghizistan 8
SN - Senegal 8
TT - Trinidad e Tobago 8
BH - Bahrain 7
AU - Australia 6
GT - Guatemala 6
IE - Irlanda 6
TH - Thailandia 6
NO - Norvegia 5
PE - Perù 5
PT - Portogallo 5
RO - Romania 5
SE - Svezia 5
TW - Taiwan 5
BY - Bielorussia 4
CG - Congo 4
DO - Repubblica Dominicana 4
GA - Gabon 4
GR - Grecia 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
HU - Ungheria 3
LT - Lituania 3
LV - Lettonia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
SV - El Salvador 3
ZM - Zambia 3
BF - Burkina Faso 2
BJ - Benin 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GF - Guiana Francese 2
GH - Ghana 2
LB - Libano 2
LU - Lussemburgo 2
Totale 14.331
Salva come PNG Salva come JPEG
Città #
Singapore 3.377
Santa Clara 754
Hong Kong 654
Hefei 482
San Jose 287
Ashburn 279
Lauterbourg 257
Seoul 196
Ho Chi Minh City 187
Beijing 177
Dallas 163
Hanoi 134
Frankfurt am Main 124
New York 93
Los Angeles 83
Tokyo 73
São Paulo 70
Tashkent 65
Buffalo 58
Istanbul 50
Nairobi 48
Milan 46
Jeddah 41
Rome 39
Baghdad 35
Kuala Lumpur 32
Amman 31
Helsinki 29
Montevideo 29
Baku 28
Caracas 25
Kingston 24
North Bergen 24
Rio de Janeiro 24
Biên Hòa 23
Minamishinagawa 23
Riyadh 23
Bengaluru 21
Belo Horizonte 20
Erbil 20
Guangzhou 20
Orem 20
Quito 20
Haiphong 19
Asunción 18
Da Nang 18
Florence 18
San José 18
Jakarta 17
Johannesburg 17
Toronto 17
Chicago 16
Curitiba 16
New Delhi 16
Nuremberg 16
Quezon City 16
Brasília 15
Casablanca 15
El Progreso 15
Lappeenranta 15
Tirana 15
Brooklyn 14
Duhok 14
Guayaquil 14
Maracaibo 14
Newark 14
Phoenix 14
Chennai 13
Council Bluffs 13
Dhaka 13
Tbilisi 13
Boardman 12
Dammam 12
Naples 12
Padova 12
Campinas 11
Genoa 11
Guarulhos 11
Montreal 11
Moscow 11
Salvador 11
Yangon 11
Abidjan 10
Izmir 10
London 10
Manila 10
Panama City 10
Ribeirão Preto 10
Sorocaba 10
Almaty 9
Bari 9
Bắc Ninh 9
Cairo 9
Cape Town 9
Delhi 9
Houston 9
Hải Dương 9
Medellín 9
Mexico City 9
Porto Alegre 9
Totale 8.935
Salva come PNG Salva come JPEG
Nome #
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models 4.803
Effects of low-carbohydrate versus mediterranean diets on weight loss, glucose metabolism, insulin kinetics and ?-cell function in morbidly obese individuals 114
The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study 111
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials 100
Prospective associations of dietary carbohydrate, fat, and protein intake with ?-cell function in the CODAM study 98
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance 86
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans 83
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study 82
Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions 81
Depressive symptoms, insulin sensitivity and insulin secretion in the RISC cohort study 81
Long-term effects of bariatric surgery on meal disposal and ss-cell function in diabetic and nondiabetic patients 81
A reference map of potential determinants for the human serum metabolome 81
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial 79
Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study 77
Author Correction: Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models (Nature Biotechnology, (2023), 41, 3, (399-408), 10.1038/s41587-022-01520-x) 75
Effects of Obesity and Exercise on Hepatic and Pancreatic Lipid Content and Glucose Metabolism: PET Studies in Twins Discordant for BMI. 73
Mechanism of progression to diabtes in relatives of type 1 Diabetic patients 71
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study 70
Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals 70
Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance 68
Methods of assessment of insulin sensitivity and beta-cell function 67
Inhibition of sweet chemosensory receptors alters insulin responses during glucose ingestion in healthy adults: A randomized crossover interventional study 67
Defective amplifying pathway of ?-cell secretory response to glucose in type 2 diabetes: Integrated modeling of in vitro and in vivo evidence 67
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes 67
Does DPP-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? - a randomized controlled trial 65
SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes 63
Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration 61
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits 61
Brain substrate metabolism and ß-cell function in humans: A positron emission tomography study 61
New insights on the interactions between insulin clearance and the main glucose homeostasis mechanisms 59
Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis 58
Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes 58
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity 58
Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response 56
Associations between sleep duration and sleep debt with insulin sensitivity and insulin secretion in the EGIR-RISC Study 56
Exenatide improves beta-cell function up to 3 years of treatment in patients with type 2 diabetes: A randomised controlled trial 56
Pharmacometrics Markup Language (PharmML): Opening new perspectives for model exchange in drug development 55
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose Sensitivity 54
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects 54
Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea 53
Influence of Hyperinsulinemia and Insulin Resistance on In Vivo beta-Cell Function Their Role in Human beta-Cell Dysfunction 53
The influence of metformin treatment on the circulating proteome 53
Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes 52
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux 51
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 51
Characterization of the Influence of Vildagliptin on Model-Assessed b-Cell Function in Patients with Type 2 Diabetes and Mild Hyperglycemia 51
Beta-cell function in obesity: effects of weight loss 50
Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study 50
Dapagliflozin lowers plasma glucose concentration and improves beta-cell function 48
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial 48
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients 48
Association of artificially sweetened and sugar-sweetened soft drinks with ?-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study 48
Influence of hepatic and peripheral insulin resistance on glucose tolerance in non diabetic subjects: the RISC study. 47
Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men 47
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes 46
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models 45
Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study 45
Model description language (MDL): A standard for modeling and simulation 45
Obesity and carotid artery remodeling 44
Glucose uptake saturation explains glucose kinetics profiles measured by different tests 44
Improvements in beta cell function parameteres during 52-week treatment with vildagliptin in patients mild hyperglycaemia 43
Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients 43
Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test 43
Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms 42
Effect of acute hyperglycemia on insulin secretion in humans 42
Post-dinner resistance exercise improves postprandial risk factors more effectively than pre-dinner resistance exercise in patients with type 2 diabetes 41
Relationships between glucose clearance during an ogtt and a euglycemic clamp 40
Effect of exenatide on postprandial glucose fluxes, lipolysis function in non-diabetic, morbidly obese patients 40
Associations of dietary glucose, fructose, and sucrose with ?-cell function, insulin sensitivity, and type 2 diabetes in the maastricht study 40
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function 39
Effect of dapagliflozin with and without acipimox on insulin sensitivity and insulin secretion in T2DM males 39
Effect of single-dose DPP-4 inhibitor sitagliptin on beta-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects 39
Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects 39
The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function 39
Valutazione dell efficacia di un farmaco antidiabetico prodotto da un azienda USA 38
The effect of a vegetarian versus conventional hypocaloric diet on serum concentrations of persistent organic pollutants in patients with type 2 diabetes 38
Glucose sensitivity, insulin sensitivity and their longitudinal changes are strong independent determinants of type 2 diabetes progression: an IMI DIRECT study 38
Beta-cells in youth with impaired glucose tolerance or early type 2 diabetes secrete more insulin and are more responsive than in adults 38
Potentiation of the early-phase insulin response by a prior meal contributes to the second-meal phenomenon in type 2 diabetes 37
Disruption of fasting and post-load glucose homeostasis are largely independent and sustained by distinct and early major beta-cell function defects: a cross-sectional and longitudinal analysis of the Relationship between Insulin Sensitivity and Cardiovascular risk (RISC) study cohort 37
Thiazolidinediones improve beta-cell function in type 2 diabetic patients 37
Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women 37
The heritability of beta cell function parameters in a mixed meal test design 36
Glucose metabolism in high-risk subjects for type 2 diabetes carrying the rs7903146 TCF7L2 gene variant 36
m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction 36
Imeglimin increases glucose-dependent insulin secretion and improves beta-cell function in patients with type 2 diabetes 36
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients 36
Methods for the assessment of beta-cell function in vivo 36
Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans 35
Efficacy and tolerability of vidagliptin in drug_naive patients with type 2 diabetes (T2DM) and mild hyperglycaemia 35
A mathematical modelling of the beta cell explaining in vitro and in vivo findings with consistent mechanisms 35
Valutazione della sensibilità all insulina e della funzione betacellulare con modelli matematici 35
Assessment of insulin sensitivity from steady-state and dynamic tests 35
Valutazione della sensibilità all insulina e della funzione beta cellulare con modelli matematici 35
The effect of alogliptin and pioglitazone combination therapy on various aspects of ?-cell function in patients with recent-onset type 2 diabetes 35
Incretin and islet hormone responses to meals of increasing size in healthy subjects 34
Age- and sex-dependent distribution of OGTT-related variables in a population of cystic fibrosis patients 34
Nonalcoholic Fatty Liver Is Not Associated with the Relationship between Insulin Secretion and Insulin Sensitivity in Obese Children: Matched Case-Control Study 34
Lifetime congenital isolated GH deficiency does not protect from the development of diabetes 34
Applicazioni di modelli matematici per la fisiologia 34
Totale 10.046
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.185
article - articoli 38.027
book - libri 217
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 0 0 0 0 0 0 0 5 0 9 4
2024/20255.163 30 28 245 154 641 136 100 86 154 620 1.523 1.446
2025/20269.104 1.039 1.342 1.494 1.274 952 220 932 341 322 327 407 454
2026/2027201 201 0 0 0 0 0 0 0 0 0 0 0
Totale 14.486